Sysmex Corporation ADR (OTCMKTS:SSMXY – Get Free Report) saw an uptick in trading volume on Monday. Approximately 798,287 shares traded hands during trading, an increase of 289% from the previous session’s volume of 205,006 shares. The stock last traded at $11.5650 and had previously closed at $11.60.
Analyst Upgrades and Downgrades
Separately, Zacks Research upgraded Sysmex from a “strong sell” rating to a “hold” rating in a research note on Tuesday, August 18th. Two investment analysts have rated the stock with a Hold rating. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold”.
Check Out Our Latest Stock Analysis on SSMXY
Sysmex Trading Down 2.1%
The company has a debt-to-equity ratio of 0.23, a current ratio of 3.40 and a quick ratio of 2.53. The stock has a market cap of $6.95 billion, a price-to-earnings ratio of 27.19 and a beta of 1.18. The company’s fifty day moving average price is $11.93 and its 200-day moving average price is $10.07.
Sysmex (OTCMKTS:SSMXY – Get Free Report) last released its earnings results on Friday, August 7th. The company reported $0.09 EPS for the quarter, topping analysts’ consensus estimates of $0.07 by $0.02. Sysmex had a net margin of 7.62% and a return on equity of 8.01%. The company had revenue of $825.85 million during the quarter, compared to analysts’ expectations of $741.67 million. Sysmex has set its FY 2026 guidance at 0.382-0.382 EPS. On average, research analysts expect that Sysmex Corporation ADR will post 0.41 EPS for the current fiscal year.
Sysmex Company Profile
Sysmex Corporation is a Japan-based healthcare technology company that develops, manufactures and distributes in vitro diagnostic products and laboratory solutions. The company is best known for its automated hematology analyzers, which are used to examine blood cells, along with related reagents, software and support services.
Its product portfolio also includes systems for hemostasis, urinalysis, clinical chemistry and immunochemistry, as well as laboratory automation and information-management solutions.
See Also
- Five stocks we like better than Sysmex
- Rate-Resilient vs. Rate-Exposed: Why Homebuilder Stocks Are Diverging
- The AI Trade Just Moved Into Your Bloodstream, and 4 Healthcare Stocks Are Winning
- 5 Beaten-Down AI Names That Could Bounce If Fear Fades
- Could AI Finally Unlock Apple’s Next Leg of Growth?
Receive News & Ratings for Sysmex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sysmex and related companies with MarketBeat.com's FREE daily email newsletter.
